PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 2, 2026Immunometabolism0 citationsOpen Access

Developmental origins of immunometabolic health

View Full Paper
YAYem J. AlharithiGSG. Richard SmithLCLizhi Cao

Key Points

  • The aim is to understand the effects of maternal obesity on the developing immune system and immunometabolic pathways in offspring.
  • Review of existing epidemiological studies and preclinical models.
  • Evaluation of metabolic and inflammatory dimensions of developmental programming.
  • Discussion of implications of maternal environmental factors.
  • Maternal obesity significantly affects offspring health risks, regardless of their own lifestyles.
  • Developmental programming shapes long-term immunometabolic health outcomes.
  • Adverse maternal environments influence offspring's immune system and metabolic pathways.

Abstract

Obesity during pregnancy not only affects maternal health but also puts offspring at high risk of obesity and of metabolic and cardiovascular diseases later in life, often regardless of their own lifestyle choices. This process, known as developmental programming, is increasingly being recognized as a critical factor shaping long-term health outcomes. In addition, a growing body of research highlights the importance of immunometabolism, the metabolism of immune cells, in the pathogenesis of obesity, metabolic disorders, cardiovascular disease, and cancer. Although the effects of maternal obesity on offspring health have been well documented in both epidemiological studies and preclinical models, its influence on the developing immune system and immunometabolic pathways is only beginning to be revealed. In this review, we explore the metabolic and inflammatory dimensions of developmental programming and discuss how an adverse maternal environment may shape the offspring’s immunometabolic landscape.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Alharithi et al. (2026) studied this question.

synapsesocial.com/papers/6980fe48c1c9540dea81042fhttps://doi.org/10.1097/in9.0000000000000075
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans2005 · 2,498 citations
  2. 2Effects of Sitagliptin on Lipid Profile in Patients With Type 2 Diabetes Mellitus After 7 Years of Therapy2019 · 12 citations
  3. 3Clinical Effectiveness of Liraglutide vs Sitagliptin on Glycemic Control and Body Weight in Patients with Type 2 Diabetes: A Retrospective Assessment in Sweden2016 · 9 citations
  4. 4Maternal Obesity and Offspring Long-Term Infectious Morbidity2019 · 32 citations
  5. 5Long-Term Safety and Efficacy of Sitagliptin for Type 2 Diabetes Mellitus in Japan: Results of a Multicentre, Open-Label, Observational Post-Marketing Surveillance Study2020 · 10 citations